Vident Investment Advisory’s Lyell Immunopharma LYEL Stock Holding History

Vident Investment Advisory’s Portfolio LYEL Stock Details LYEL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$522K	Sell
2022 Q4	$773K	Buy
2022 Q3	$969K	Sell
2022 Q2	$955K	Buy